{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:59:25Z","timestamp":1782842365631,"version":"3.54.5"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ucl.2026.03.010","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:52:02Z","timestamp":1777499522000},"page":"463-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes"],"prefix":"10.1016","volume":"53","author":[{"given":"Sha","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Samuel L.","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Sekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carissa E.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ucl.2026.03.010_bib1","article-title":"What are health disparities?","author":"Health","year":"2025","journal-title":"National Institute on Minority Health and Health Disparities"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib2","first-page":"31","article-title":"Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy","volume":"70","author":"Alcaraz","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ucl.2026.03.010_bib3","unstructured":"Organization, W.H., Social determinants of health. 2025."},{"issue":"6","key":"10.1016\/j.ucl.2026.03.010_bib4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.010_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11606-014-3116-2","article-title":"Gender, race, and variation in the evaluation of microscopic hematuria among medicare beneficiaries","volume":"30","author":"Bassett","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"7","key":"10.1016\/j.ucl.2026.03.010_bib6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2105\/AJPH.2012.300750","article-title":"The problem with the phrase women and minorities: intersectionality-an important theoretical framework for public health","volume":"102","author":"Bowleg","year":"2012","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.010_bib7","first-page":"613","article-title":"Geographic distribution of racial differences in mortality in muscle-invasive bladder cancer patients: an opportunity for improvement","volume":"33","author":"Freudenburg","year":"2022","journal-title":"Cancer Causes Control"},{"issue":"7","key":"10.1016\/j.ucl.2026.03.010_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/jnci\/djac030","article-title":"Rural-urban disparities in cancer outcomes: opportunities for future research","volume":"114","author":"Bhatia","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.010_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/JU.0000000000004490","article-title":"Updates to microhematuria: AUA\/SUFU guideline (2025)","volume":"213","author":"Barocas","year":"2025","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.010_bib10","doi-asserted-by":"crossref","first-page":"300.e1","DOI":"10.1016\/j.urolonc.2019.01.007","article-title":"Disparities in the diagnostic evaluation of microhematuriaand implications for the detection of urologic malignancy","volume":"37","author":"Matulewicz","year":"2019","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.010_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/bju.16380","article-title":"Racial disparities in stage at bladder cancer diagnosis in the US veterans affairs healthcare system","volume":"134","author":"Bree","year":"2024","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12967-020-02308-w","article-title":"Ethnicity and survival in bladder cancer: a population-based study based on the SEER database","volume":"18","author":"Fang","year":"2020","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/cam4.4917","article-title":"Racial inequity and other social disparities in the diagnosis and management of bladder cancer","volume":"12","author":"Hasan","year":"2023","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib15","article-title":"The influence of health literacy on the timely diagnosis of symptomatic cancer: a systematic review","volume":"28","author":"Humphrys","year":"2019","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.010_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoncol.2017.3846","article-title":"Trends in Cancer Survival by Health Insurance Status in California from 1997 to 2014","volume":"4","author":"Ellis","year":"2018","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.010_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/cncr.28416","article-title":"Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation","volume":"120","author":"Cohn","year":"2014","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ucl.2026.03.010_bib18","doi-asserted-by":"crossref","first-page":"431.e7-e14","DOI":"10.1016\/j.urolonc.2023.05.019","article-title":"Underutilization of intravesical chemotherapy and immunotherapy for high grade non-muscle invasive bladder cancer in California between 2006-2018: effect of race, age and socioeconomic status on treatment disparities","volume":"41","author":"Noel","year":"2023","journal-title":"Urol Oncol"},{"issue":"16","key":"10.1016\/j.ucl.2026.03.010_bib19","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1200\/JCO.2015.64.4070","article-title":"Definitions, end points, and clinical trial designs for non-muscle-invasive bladder cancer: recommendations from the International Bladder Cancer Group","volume":"34","author":"Kamat","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ucl.2026.03.010_bib20","unstructured":"Administration, U.S.F.a.D., BCG supply and shortage update presentation. 2025."},{"issue":"12","key":"10.1016\/j.ucl.2026.03.010_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11934-019-0952-y","article-title":"Current clinical trials in non-muscle-invasive bladder cancer: heightened need in an era of chronic BCG shortage","volume":"20","author":"Packiam","year":"2019","journal-title":"Curr Urol Rep"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.010_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1200\/JCO.2015.62.0468","article-title":"Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors","volume":"34","author":"Yabroff","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2026.03.010_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in Situ)-A summary of the 2024 guidelines update","volume":"86","author":"Gontero","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.03.010_bib24","first-page":"1","article-title":"Geography should not be an \u201cOncologic Destiny\u201d for urothelial cancer: improving access to care by removing local, regional, and international barriers","volume":"42","author":"Joshi","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"10","key":"10.1016\/j.ucl.2026.03.010_bib25","doi-asserted-by":"crossref","first-page":"796.e1","DOI":"10.1016\/j.urolonc.2020.04.026","article-title":"Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members","volume":"38","author":"Matulay","year":"2020","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.010_bib26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jamainternmed.2014.245","article-title":"Continuity and the costs of care for chronic disease","volume":"174","author":"Hussey","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ucl.2026.03.010_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.urology.2019.06.021","article-title":"Compliance with American Urological Association Guidelines for nonmuscle invasive bladder cancer remains poor: assessing factors associated with noncompliance and survival in a rural state","volume":"132","author":"Tobert","year":"2019","journal-title":"Urology"},{"issue":"10","key":"10.1016\/j.ucl.2026.03.010_bib28","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00345-019-02697-8","article-title":"Prognostic impact of non-adherence to follow-up cystoscopy in non-muscle-invasive bladder cancer (NMIBC)","volume":"37","author":"Datovo","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.ucl.2026.03.010_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.urology.2019.04.036","article-title":"Overuse of cystoscopic surveillance among patients with low-risk non-muscle-invasive bladder cancer - a national study of patient, provider, and facility factors","volume":"131","author":"Han","year":"2019","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.010_bib30","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.juro.2017.10.049","article-title":"Financial toxicity among patients with bladder cancer: reasons for delay in care and effect on quality of life","volume":"199","author":"Casilla-Lennon","year":"2018","journal-title":"J Urol"},{"issue":"16","key":"10.1016\/j.ucl.2026.03.010_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35995","article-title":"Fatigue and related variables in bladder cancer treatment - longitudinal pilot study","volume":"10","author":"Zdun-Ry\u017cewska","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ucl.2026.03.010_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2017.07.016","article-title":"The burden of cystoscopic bladder cancer surveillance: anxiety, discomfort, and patient preferences for decision making","volume":"108","author":"Koo","year":"2017","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.010_bib33","first-page":"397","article-title":"Flexible cystoscopy can improve anxiety and subjective feelings of bladder cancer patients during follow-up","volume":"16","author":"Gao","year":"2021","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.010_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2026.03.010_bib35","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1016\/j.clgc.2020.03.013","article-title":"Quantifying the overall survival benefit with early radical cystectomy for patients with histologically confirmed T1 non-muscle-invasive bladder cancer","volume":"18","author":"Tully","year":"2020","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.010_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000499257","article-title":"Survival outcomes of early versus deferred cystectomy for high-grade non-muscle-invasive bladder cancer: a systematic review","volume":"14","author":"Wan","year":"2020","journal-title":"Curr Urol"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.010_bib37","doi-asserted-by":"crossref","first-page":"255.e15","DOI":"10.1016\/j.urolonc.2022.11.005","article-title":"Disparities in the prevalence and management of high-risk non-muscle invasive bladder cancer","volume":"41","author":"Estevez","year":"2023","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib38","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.3747\/co.22.2052","article-title":"Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer","volume":"22","author":"Santos","year":"2015","journal-title":"Curr Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.010_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.euo.2019.09.008","article-title":"A systematic review and meta-analysis of delay in radical cystectomy and the effect on survival in bladder cancer patients","volume":"3","author":"Russell","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2026.03.010_bib40","doi-asserted-by":"crossref","first-page":"294.e19","DOI":"10.1016\/j.urolonc.2022.11.007","article-title":"Disparities in access to high-volume centers and in hospital discharge status following radical cystectomy in Florida","volume":"41","author":"Baird","year":"2023","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.010_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.euo.2019.11.005","volume":"3","author":"Bruins","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.010_bib42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/BLC-160058","article-title":"The relationship between centralization of care and geographic barriers to cystectomy for bladder cancer","volume":"2","author":"Casey","year":"2016","journal-title":"Bladder Cancer"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.010_bib43","first-page":"91","article-title":"Effect of centralization on complex surgical care: a population-based case study of radical cystectomy","volume":"14","author":"Siemens","year":"2020","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eururo.2012.08.050","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: urinary diversion","volume":"63","author":"Hautmann","year":"2013","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.010_bib45","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/cncr.22058","article-title":"Variations in reconstruction after radical cystectomy","volume":"107","author":"Gore","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.010_bib46","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1016\/j.clgc.2022.03.003","article-title":"Long-term health-related quality of life (HRQOL) after radical cystectomy and urinary diversion - a propensity score-matched analysis","volume":"20","author":"Volz","year":"2022","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/BLC-170162","article-title":"Disparities in the use of continent urinary diversions after radical cystectomy for bladder cancer","volume":"4","author":"Farber","year":"2018","journal-title":"Bladder Cancer"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.010_bib48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3961\/jpmph.18.092","article-title":"Demographic and survivorship disparities in non-muscle-invasive bladder cancer in the United States","volume":"51","author":"Seo","year":"2018","journal-title":"J Prev Med Public Health"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00345-024-05422-2","article-title":"Socioeconomic disparities in survival of patients with non-muscle invasive urothelial carcinoma","volume":"43","author":"Baralo","year":"2025","journal-title":"World J Urol"},{"issue":"9","key":"10.1016\/j.ucl.2026.03.010_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14490","article-title":"Impact of delay in cystoscopic surveillance on recurrence and progression rates in patients with non-muscle-invasive bladder cancer during the COVID-19 pandemic","volume":"75","author":"Culpan","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.010_bib51","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/23523735241289237","article-title":"Achieving health equity in bladder cancer care: addressing disparities through collaborative research and evidence-based strategies","volume":"10","author":"Castellon-Lopez","year":"2024","journal-title":"Bladder Cancer"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.010_bib52","doi-asserted-by":"crossref","first-page":"69.e17","DOI":"10.1016\/j.urolonc.2024.01.001","article-title":"Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: results from a machine learning-based analysis of a large multi-institutional database","volume":"42","author":"Porreca","year":"2024","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.010_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.focus.2025.100385","article-title":"Associations between transportation barriers in the context of other social needs and cancer screening adherence","volume":"4","author":"Morenz","year":"2025","journal-title":"AJPM Focus"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.010_bib54","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle Invasive Bladder Cancer: AUA\/SUO Guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.010_bib55","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MOU.0000000000000078","article-title":"The burden of bladder cancer care: direct and indirect costs","volume":"24","author":"Mossanen","year":"2014","journal-title":"Curr Opin Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib56","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cncr.24701","article-title":"Racial differences in treatment and outcomes among patients with early stage bladder cancer","volume":"116","author":"Hollenbeck","year":"2010","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.ucl.2026.03.010_bib57","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/cncr.28147","article-title":"Recurrence of high-risk bladder cancer: a population-based analysis","volume":"119","author":"Chamie","year":"2013","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ucl.2026.03.010_bib58","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/bju.15334","article-title":"Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer","volume":"128","author":"Richters","year":"2021","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.010_bib59","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1097\/NCC.0000000000000606","article-title":"Quality of life in non-muscle-invasive bladder cancer survivors: a systematic review","volume":"42","author":"Jung","year":"2019","journal-title":"Cancer Nurs"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.010_bib60","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2021.09.018","article-title":"Health-related quality of life for patients undergoing radical cystectomy: results of a large prospective cohort","volume":"81","author":"Clements","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.03.010_bib61","series-title":"Disparities in cancer survivorship in AACR cancer progress report 2024","year":"2024"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.010_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkae093","article-title":"The intersection of travel burdens and financial hardship in cancer care: a scoping review","volume":"8","author":"Planey","year":"2024","journal-title":"JNCI Cancer Spectr"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.010_bib63","article-title":"Financial toxicity of cancer care: it\u2019s time to intervene","volume":"108","author":"Zafar","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.010_bib64","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.juro.2008.10.034","article-title":"Geographic distribution of urologists throughout the United States using a county level approach","volume":"181","author":"Odisho","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2026.03.010_bib65","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.urology.2025.07.041","article-title":"Assessing the supply, demand, and adequacy of urologic surgeons in the United States: forecasting shortages to 2037","volume":"206","author":"Silvestre","year":"2025","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ucl.2026.03.010_bib66","first-page":"139","article-title":"Bladder cancer stage and mortality: urban vs. rural residency","volume":"32","author":"Deuker","year":"2021","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ucl.2026.03.010_bib67","series-title":"Telehealth: mapping the evidence for patient outcomes from systematic reviews","article-title":"AHRQ comparative effectiveness technical briefs","author":"Totten","year":"2016"},{"issue":"10","key":"10.1016\/j.ucl.2026.03.010_bib68","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/jamainternmed.2020.2666","article-title":"Assessment of disparities in digital access among medicare beneficiaries and implications for telemedicine","volume":"180","author":"Roberts","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ucl.2026.03.010_bib69","unstructured":"(ACCC), A.o.C.C.C., Understanding and mitigating disparities in bladder cancer care. 2022."},{"key":"10.1016\/j.ucl.2026.03.010_bib70","unstructured":"(ACCC), A.o.C.C.C., Mitigating disparities with guideline-based care. 2022."},{"issue":"10077","key":"10.1016\/j.ucl.2026.03.010_bib71","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","article-title":"Structural racism and health inequities in the USA: evidence and interventions","volume":"389","author":"Bailey","year":"2017","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.ucl.2026.03.010_bib72","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1200\/JCO.23.01290","article-title":"Systematic review of interventions addressing racial and ethnic disparities in cancer care and health outcomes","volume":"42","author":"Grant","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib73","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41389-023-00489-9","article-title":"Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions","volume":"12","author":"Doshi","year":"2023","journal-title":"Oncogenesis"},{"issue":"23","key":"10.1016\/j.ucl.2026.03.010_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16234100","article-title":"Sex disparities in bladder cancer diagnosis and treatment","volume":"16","author":"Pignot","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.010_bib75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41585-023-00806-2","article-title":"The sex gap in bladder cancer survival - a missing link in bladder cancer care?","volume":"21","author":"Toren","year":"2024","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/BLC-200397","article-title":"Evaluating patient-defined priorities for female patients with bladder cancer","volume":"7","author":"Vo","year":"2021","journal-title":"Bladder Cancer"},{"issue":"19","key":"10.1016\/j.ucl.2026.03.010_bib77","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.ucl.2026.03.010_bib78","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.23.00933","article-title":"Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update","volume":"41","author":"Dale","year":"2023","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.ucl.2026.03.010_bib79","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1200\/JCO.2015.63.0319","article-title":"Improving the evidence base for treating older adults with cancer: American Society of clinical oncology statement","volume":"33","author":"Hurria","year":"2015","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.ucl.2026.03.010_bib80","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1200\/JCO.19.02809","article-title":"Defining undertreatment and overtreatment in older adults with cancer: a scoping literature review","volume":"38","author":"DuMontier","year":"2020","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.010_bib81","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/cncr.32562","article-title":"The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years","volume":"126","author":"Fletcher","year":"2020","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ucl.2026.03.010_bib82","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnci\/djaa043","article-title":"The affordable care Act\u2019s Medicaid expansion and impact along the cancer-care continuum: a systematic review","volume":"112","author":"Moss","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.ucl.2026.03.010_bib83","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1470-2045(23)00293-0","article-title":"Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment","volume":"24","author":"Han","year":"2023","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib84","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.euf.2019.04.002","article-title":"Recurrence rate and cost consequence of the shortage of bacillus Calmette-Gu\u00e9rin connaught strain for bladder cancer patients","volume":"7","author":"Ourfali","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ucl.2026.03.010_bib85","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.urology.2023.02.044","article-title":"Variation in statewide intravesical treatment rates for non-muscle invasive bladder cancer during the bacillus calmette-guerin drug shortage","volume":"177","author":"Chun","year":"2023","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2026.03.010_bib86","unstructured":"(CMS), C.f.M.M.S, Stratified reporting (CMS health equity measurement work). 2025."},{"issue":"16","key":"10.1016\/j.ucl.2026.03.010_bib87","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1001\/jama.2024.2440","article-title":"Health equity adjustment and Hospital performance in the Medicare Value-Based Purchasing Program","volume":"331","author":"Liu","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ucl.2026.03.010_bib88","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.socscimed.2013.06.032","article-title":"Structural competency: theorizing a new medical engagement with stigma and inequality","volume":"103","author":"Metzl","year":"2014","journal-title":"Soc Sci Med"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.010_bib89","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11606-010-1529-0","article-title":"Does cultural competency training of health professionals improve patient outcomes? A systematic review and proposed algorithm for future research","volume":"26","author":"Lie","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib90","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7326\/0003-4819-157-1-201207030-00450","article-title":"Effect of clinical decision-support systems: a systematic review","volume":"157","author":"Bright","year":"2012","journal-title":"Ann Intern Med"},{"issue":"6464","key":"10.1016\/j.ucl.2026.03.010_bib91","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1126\/science.aax2342","article-title":"Dissecting racial bias in an algorithm used to manage the health of populations","volume":"366","author":"Obermeyer","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib92","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41746-025-02119-7","article-title":"Potential for algorithmic bias in clinical decision instrument development","volume":"8","author":"Obra","year":"2025","journal-title":"npj Digit Med"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib93","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat Commun"},{"issue":"697","key":"10.1016\/j.ucl.2026.03.010_bib94","doi-asserted-by":"crossref","first-page":"eabn4118","DOI":"10.1126\/scitranslmed.abn4118","article-title":"Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical bacillus calmette-gu\u00e9rin","volume":"15","author":"de Jong","year":"2023","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.ucl.2026.03.010_bib95","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1200\/OP.23.00153","article-title":"Importance of patient health insurance coverage and out-of-pocket costs for genomic testing in oncologists\u2019 treatment decisions","volume":"20","author":"Yabroff","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.010_bib96","doi-asserted-by":"crossref","first-page":"oyaf067","DOI":"10.1093\/oncolo\/oyaf067","article-title":"A rising tide lifts all boats in the personalized cancer care continuum for mNSCLC: bridging inequities in NGS fosters equity in targeted treatment","volume":"30","author":"Lin","year":"2025","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ucl.2026.03.010_bib97","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s12916-025-04340-3","article-title":"Navigating fairness aspects of clinical prediction models","volume":"23","author":"Chakradeo","year":"2025","journal-title":"BMC Med"},{"issue":"12","key":"10.1016\/j.ucl.2026.03.010_bib98","doi-asserted-by":"crossref","first-page":"e2138219","DOI":"10.1001\/jamanetworkopen.2021.38219","article-title":"Trends in use of next-generation sequencing in patients with solid tumors by race and ethnicity after implementation of the medicare national coverage determination","volume":"4","author":"Sheinson","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.ucl.2026.03.010_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103373","article-title":"Equitable inclusion of diverse populations in oncology clinical trials: deterrents and drivers","volume":"9","author":"Vidal","year":"2024","journal-title":"ESMO Open"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014326000364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014326000364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:36:37Z","timestamp":1782840997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014326000364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0094014326000364"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2026.03.010","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2026.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}